NAFLD - Non-Alcoholic Fatty Liver Disease Clinical Trials in Guangzhou, Guangdong

a Safety, Tolerability, and Pharmacokinetic Trial of Multiple Subcutaneous Injections of B1344 Injection in Patients With Nonalcoholic Fatty Liver Disease（NAFLD）